BELLADONNA, Maria Laura
 Distribuzione geografica
Continente #
NA - Nord America 2.448
EU - Europa 2.281
AS - Asia 588
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 2
OC - Oceania 1
Totale 5.340
Nazione #
US - Stati Uniti d'America 2.423
IT - Italia 606
IE - Irlanda 470
UA - Ucraina 354
HK - Hong Kong 264
SE - Svezia 255
VN - Vietnam 194
RO - Romania 117
DE - Germania 98
FI - Finlandia 97
FR - Francia 96
CN - Cina 92
RU - Federazione Russa 67
BE - Belgio 37
GB - Regno Unito 32
CA - Canada 24
CH - Svizzera 21
CI - Costa d'Avorio 12
TR - Turchia 11
GR - Grecia 9
NL - Olanda 8
UZ - Uzbekistan 8
EU - Europa 7
LB - Libano 6
AT - Austria 5
IN - India 5
PL - Polonia 4
CZ - Repubblica Ceca 3
BR - Brasile 2
JP - Giappone 2
KR - Corea 2
AU - Australia 1
HU - Ungheria 1
IR - Iran 1
LK - Sri Lanka 1
MX - Messico 1
NG - Nigeria 1
PH - Filippine 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.340
Città #
Chandler 506
Dublin 465
Perugia 399
Hong Kong 264
San Mateo 244
Dong Ket 194
Jacksonville 193
Bucharest 117
Redmond 113
Medford 101
Wilmington 101
Princeton 100
Ann Arbor 86
Altamura 81
Lawrence 75
Beijing 66
Andover 57
Des Moines 48
Falls Church 45
Brussels 37
Boardman 30
Dearborn 30
Saint Petersburg 28
Pisa 26
Ashburn 23
Norwalk 22
Woodbridge 22
San Paolo di Civitate 18
Fremont 17
Ottawa 17
Helsinki 16
Abidjan 12
New York 12
Izmir 10
Redwood City 9
San Diego 9
Los Angeles 8
Den Haag 6
Fairfield 5
Cambridge 4
Chicago 4
Hanover 4
Houston 4
Nanjing 4
Nanning 4
Winnipeg 4
Auburn Hills 3
Civitanova Marche 3
Frankfurt Am Main 3
Lappeenranta 3
Ludwigshafen 3
Moscow 3
Nichelino 3
Nürnberg 3
Paris 3
Tacoma 3
Tappahannock 3
Toronto 3
Chennai 2
Hefei 2
Jinan 2
Kālpākkam 2
Lausanne 2
L’Aquila 2
Milan 2
Planegg 2
Rio De Janeiro 2
Romainville 2
Rome 2
Saint Louis 2
Saint Peters 2
San Jose 2
Silea 2
Terni 2
Vicenza 2
West Jordan 2
Amsterdam 1
Angeles 1
Assisi 1
Athens 1
Azcapotzalco 1
Baotou 1
Bologna 1
Boston 1
Boydton 1
Bratislava 1
Budapest 1
Carrollton 1
Castel Maggiore 1
Castiglione del Lago 1
Changsha 1
Chaoyang 1
Chengdu 1
Collazzone 1
Dambulla 1
Edinburgh 1
Esslingen am Neckar 1
Falkenstein 1
Freiburg 1
Gaziantep 1
Totale 3.736
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 133
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 131
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 123
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 116
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 114
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 113
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 111
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 106
Amino-acid sensing and degrading pathways in immune regulation 103
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 102
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 100
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 97
The TGF-β/IDO axis in infectious tolerance. 84
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 83
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 79
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 76
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 76
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 75
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 74
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 74
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance 73
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 72
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 71
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 71
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 69
Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents. 69
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 67
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 66
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 65
Modulation of tryptophan catabolism by regulatory T cells 64
Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. 64
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 62
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 62
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 61
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 61
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 58
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 58
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 56
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 56
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 56
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 53
The IL-23/IL-17 pathway impairs antifungal immune resistance 52
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 51
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 51
METODO PER LA REALIZZAZIONE DI UNA COMPOSIZIONE PER USO FARMACEUTICO COMPRENDENTE CELLULE DENDRITICHE E COMPOSIZIONE PER USO FARMACEUTICO COSI' OTTENUTA 50
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 50
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 49
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. 49
CTLA-4-Ig regulates tryptophan catabolism in vivo. 47
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 46
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 46
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 46
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 45
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. 45
Negative vaccination with IGRP-pulsed dendritic cells expressing ectopic IL-35Ig prevents the development of NOD autoimmune Diabetes 45
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 44
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 42
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 41
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 41
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 41
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 41
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 40
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 40
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 39
Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. 39
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 39
Anti-osteoclastogenic activity of Crocus sativus petal extract: turning saffron waste into a valuable resource against bone disruption. 39
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 38
IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. 37
IL-23 gene therapy for mouse bladder tumour cell lines. 37
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 37
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 36
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 36
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. 35
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 35
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. 35
Potentent antitumor activity of interleukin-27. 35
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 35
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model 35
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 34
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 34
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer 34
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 33
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. 33
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 33
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 32
TGF-beta and kynurenines as the key to infectious tolerance. 32
Tryptophan catabolism in nonobese diabetic mice. 32
PRODUCTION OF MEMBRANE AND SOLUBLE PD-L1 BY LUNG TUMOR CELLS 32
Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 32
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 31
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 31
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. 30
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 29
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 27
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 24
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 23
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 23
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 22
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 21
Totale 5.515
Categoria #
all - tutte 18.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201934 0 0 0 0 0 0 0 0 0 10 19 5
2019/2020576 16 10 71 10 63 31 79 34 110 64 25 63
2020/20211.049 8 53 29 60 297 65 95 10 109 38 76 209
2021/20221.242 19 179 20 48 55 31 14 276 153 102 117 228
2022/20231.660 112 283 12 153 151 173 1 81 611 17 49 17
2023/2024516 37 92 25 11 11 12 206 22 81 19 0 0
Totale 5.651